CTx Scientific Advisor

Dr Ian Street

Dr Street has an extensive background in commercial and academic drug discovery and brings valuable industry links, R&D expertise, and business acumen to the Company.

He oversees and directs Cancer Therapeutics CRC’s R&D program and project portfolio.  He also manages the Company’s technology relationship with partners and stakeholders and is responsible for the Portfolio Management Group, our main forum for evaluating and selecting new projects and monitoring the performance of projects in the pipeline.

Dr Street comes to the company from the Walter and Eliza Hall Institute (WEHI), where he established and ran the very successful Centre for High Throughput Chemical Screening.  Before working at WEHI, he established similar drug discovery facilities at Merck, Amrad, Cerylid and Bionomics.  During his career, he has participated in drug discovery collaborations with Aventis, Chugai Pharmaceuticals, Chiron, BiochemPharma, Genentech and Abbott.